Your browser doesn't support javascript.
loading
A Novel Controlled PTEN-Knockout Mouse Model for Prostate Cancer Study.
Liu, Sen; Zhang, Bing; Rowan, Brian G; Jazwinski, S Michal; Abdel-Mageed, Asim B; Steele, Chad; Wang, Alun R; Sartor, Oliver; Niu, Tianhua; Zhang, Qiuyang.
Afiliação
  • Liu S; Department of Structural and Cellular Biology, Tulane University School of Medicine, New Orleans, LA, United States.
  • Zhang B; Department of Structural and Cellular Biology, Tulane University School of Medicine, New Orleans, LA, United States.
  • Rowan BG; Medical Laboratory of ShenZhen LuoHu People's Hospital, Shenzhen, China.
  • Jazwinski SM; Department of Structural and Cellular Biology, Tulane University School of Medicine, New Orleans, LA, United States.
  • Abdel-Mageed AB; Department of Medicine, Tulane University School of Medicine, New Orleans, LA, United States.
  • Steele C; Tulane Center for Aging, Tulane University School of Medicine, New Orleans, LA, United States.
  • Wang AR; Department of Urology, Tulane University School of Medicine, New Orleans, LA, United States.
  • Sartor O; Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA, United States.
  • Niu T; Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA, United States.
  • Zhang Q; Department of Urology, Tulane University School of Medicine, New Orleans, LA, United States.
Front Mol Biosci ; 8: 696537, 2021.
Article em En | MEDLINE | ID: mdl-34150854
ABSTRACT
Prostate cancer (PCa) is associated with advanced age, but how age contributes to prostate carcinogenesis remains unknown. The prostate-specific Pten conditional knockout mouse model closely imitates human PCa initiation and progression. To better understand how age impacts PCa in an experimental model, we have generated a spatially and temporally controlled Pten-null PCa murine model at different ages (aged vs. non-aged) of adult mice. Here, we present a protocol to inject the Cre-expressing adenovirus with luciferin tag, intraductally, into the prostate anterior lobes of Pten-floxed mice; Pten-loss will be triggered post-Cre expression at different ages. In vivo imaging of luciferin signal following viral infection confirmed successful delivery of the virus and Cre activity. Immunohistochemical staining confirmed prostate epithelial-specific expression of Cre recombinase and the loss of Pten and activation of P-Akt, P-S6, and P-4E-BP1. The Cre-expression, Pten ablation, and activated PI3K/AKT/mTOR pathways were limited to the prostate epithelium. All mice developed prostatic epithelial hyperplasia within 4 weeks after Pten ablation and prostatic intraepithelial neoplasia (PIN) within 8 weeks post-Pten ablation. Some PINs had progressed to invasive adenocarcinoma at 8-16 weeks post-Pten ablation. Aged mice exhibited significantly accelerated PI3K/AKT/mTOR signaling and increased PCa onset and progression compared to young mice. The viral infection success rate is ∼80%. This model will be beneficial for investigations of cancer-related to aging.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article